Elevance Health, Inc.
American healthcare company
ELV NYSE
ISIN US0367521038 SEC CIK 1156039 LEI 8MYN82XMYQH89CTMTH67
Follow Elevance Health
Weekly email: filings, results
Revenue, last quarter
$51.4B
+1.4% vs same quarter last year
Net income
$1.4B
+14.8% vs same quarter last year
EPS, diluted
$6.27
+17.9% vs same quarter last year
Operating cash flow
$1.3B
+11.6% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $199.1B | $5.7B |
| FY24 | $177B | $6B |
| FY23 | $171.3B | $6B |
| FY22 | $156.6B | $5.9B |
| FY21 | $138.6B | $6.2B |
| FY20 | $121.9B | $4.6B |
| FY19 | $104.2B | $4.8B |
| FY18 | $92.1B | $3.8B |
| FY17 | $90B | $3.8B |
| FY16 | $84.9B | $2.5B |
| FY15 | $79.2B | $2.6B |
| FY14 | $73.9B | $2.6B |
| FY13 | $71B | $2.5B |
| FY12 | $61.5B | $2.7B |
| FY11 | $60.7B | $2.6B |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 89.4% | 3.6% | 2.8% |
| FY24 | 88.8% | 4.4% | 3.4% |
| FY23 | 89.9% | 5% | 3.5% |
| FY22 | 91.7% | 5.3% | 3.8% |
| FY21 | 92.1% | 5.5% | 4.4% |
| FY20 | 92.7% | 5.2% | 3.8% |
| FY19 | 98.1% | 5.8% | 4.6% |
| FY18 | 100% | 5.9% | 4.1% |
| FY17 | 100% | 4.6% | 4.3% |
| FY16 | - | 5.7% | 2.9% |
| FY15 | - | 6% | 3.2% |
| FY14 | - | 6% | 3.5% |
| FY13 | - | 5.6% | 3.5% |
| FY12 | 99.8% | 5.9% | 4.3% |
| FY11 | 100% | 6.2% | 4.4% |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | $3.2B |
| FY24 | $4.6B |
| FY23 | $6.8B |
| FY22 | $7.2B |
| FY21 | $7.3B |
| FY20 | $9.7B |
| FY19 | $5B |
| FY18 | $2.6B |
| FY17 | $3.4B |
| FY16 | $2.7B |
| FY15 | $3.6B |
| FY14 | $2.7B |
| FY13 | $2.4B |
| FY12 | $2.2B |
| FY11 | $2.9B |
- Dividends
- Buybacks
Show the numbers
| Year | Dividends | Buybacks |
|---|---|---|
| FY25 | $1.5B | $2.6B |
| FY24 | $1.5B | $2.9B |
| FY23 | $1.4B | $2.7B |
| FY22 | $1.2B | $2.3B |
| FY21 | $1.1B | $1.9B |
| FY20 | $954M | $2.7B |
| FY19 | $818M | $1.7B |
| FY18 | $776M | $1.7B |
| FY17 | $705M | $2B |
| FY16 | $684M | $0 |
| FY15 | $656.6M | $1.5B |
| FY14 | $480.7M | $3B |
| FY13 | $448M | $1.6B |
| FY12 | $367.1M | $2.5B |
| FY11 | $357.8M | $3B |
- Elevance Health
- Financials median
Show the numbers
| Year | Elevance Health | Financials median |
|---|---|---|
| FY25 | 2.8% | 12.6% |
| FY24 | 3.4% | 13.7% |
| FY23 | 3.5% | 11.5% |
| FY22 | 3.8% | 12.8% |
| FY21 | 4.4% | 18.9% |
| FY20 | 3.8% | 13.3% |
| FY19 | 4.6% | 14.4% |
| FY18 | 4.1% | 17.2% |
| FY17 | 4.3% | 11% |
| FY16 | 2.9% | 11.5% |
| FY15 | 3.2% | 9.3% |
| FY14 | 3.5% | 10.1% |
| FY13 | 3.5% | 9.7% |
| FY12 | 4.3% | 8.6% |
| FY11 | 4.4% | 6.5% |